Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 350,522 shares at $58.35 ($20.4M) on 2025-02-18, disclosed to the SEC on 2025-02-20.
Scheduled sale ($20.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.85 | 14,784 | $855K | 4.2% |
| 2 | $57.85 | 14,784 | $855K | 4.2% |
| 3 | $57.86 | 33,347 | $1.9M | 9.5% |
| 4 | $57.86 | 33,347 | $1.9M | 9.5% |
| 5 | $58.22 | 31,257 | $1.8M | 8.9% |
| 6 | $58.22 | 31,257 |
| $1.8M |
| 8.9% |
| 7 | $58.26 | 81,660 | $4.8M | 23.3% |
| 8 | $58.26 | 81,660 | $4.8M | 23.3% |
| 9 | $58.35 | 1,992 | $116K | 0.6% |
| 10 | $58.35 | 1,992 | $116K | 0.6% |
| 11 | $59.54 | 1,493 | $89K | 0.4% |
| 12 | $59.54 | 1,493 | $89K | 0.4% |
| 13 | $59.57 | 10,328 | $615K | 3.0% |
| 14 | $59.57 | 10,328 | $615K | 3.0% |
| 15 | $59.69 | 800 | $48K | 0.2% |
| Total | $58.23 avg | 350,522 | $20.4M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |